“경산건마🚽 〔ØΡＤΑＬⓞ④ⓞㆍㄷΘм〕오피달리기 👧경산아로마👨경산휴게텔👈경산출장안마🏦경산아로마🌸경산키스방🙈경산OP🙄”的搜索结果，显示 241-250 项，共有 16927 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Bio-bank for Patients with Inflammatory Bowel Disease Associated Neoplasia. Rochester, Minn. The purpose of this study is to collect blood and stool samples ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer. Rochester, Minn., ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer. Rochester, Minn., ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In ...